This announcement is a separate document:
天康生物：关于以债转股方式向全资子公司增资的进展公告
Tiankang Biotech: Announcement on the progress of capital increase to wholly-owned subsidiaries through debt-for-equity swaps
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated